Versant’s global biotech team is reloading with $350M-plus fund
After racking up dozens of biotech investments on both sides of the Atlantic over the past 17 years, the prolific and influential team at Versant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
